Selected Publications

Publications

• Winterstein AG, Bussing R, Goodin A, Xu D, Keenan M, Turner K, Meyyur V, Duseja R, Campbell K. Development and Validation of an Administrative Claims-based Measure for All-cause 30-day Risk-standardized Readmissions After Discharge From Inpatient Psychiatric Facilities. Medical Care. 2020 Mar 5;58(3):225-33. https://journals.lww.com/lww-medicalcare/Citation/2020/03000/Development_and_Validation_of_an_Administrative.6.aspx

• Sarayani A, Albogami Y, Elkhider M, Hincapie-Castillo JM, Brumback BA, Winterstein AG. Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate. BMJ quality & safety. 2019 Oct 24:bmjqs-2019. http://dx.doi.org/10.1136/bmjqs-2019-010098

• Li Y, Delcher C, Brown JD, Wei YJ, Reisfield GM, Winterstein AG. Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis. Drug and alcohol dependence. 2019 Sep 1;202:172-7. https://doi.org/10.1016/j.drugalcdep.2019.05.025

News Release